To prevent the extensive apoptosis‐induced deletion of immune effector cells in patients with sepsis, one potential strategy is the use of anti‐apoptotic, immunostimulatory cytokines, such as IL‐7 and IL‐15; both agents have shown efficacy in models of sepsis. This evidence concerns the gene IL15 and Sepsis.